There is 1 paper on P53 and P21 immunoreactivity in aging research: none in people yet, 1 in animals.
1 paper studies it1 finding
See all 1 papers on P53 and P21 immunoreactivity
- Animals1
Interventions
1Chitosan oligosaccharide
downin mice1
1 study
Chitosan oligosaccharide
downin mice1
Chitosan oligosaccharide decreases P53 and P21 immunoreactivity in mice (naturally aged mice, long-term supplementation).
“COS mitigated age-associated body weight gain and was accompanied by reduced p53 and p21 immunoreactivity in brain and kidney”
Animalsnaturally aged mice, long-term supplementationbrain and kidney10 to 18 monthsmales
Impact of chitosan oligosaccharide on microbiota-metabolite-immune axis in natural aging
Frontiers in nutrition
Latest
1 paper in 12 monthsFrontiers in Nutrition
Impact of chitosan oligosaccharide on microbiota-metabolite-immune axis in natural aging
Experiments in miceGut and microbiome